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In December 2011, the European Science Foundation (ESF) brought together experts from
a wide range of disciplines to discuss the issues that will influence the development of
a healthier, more brain-aware European society. This perspective summarizes the main
outcomes of that discussion and highlights important considerations to support improved
mental health in Europe, including:
1. The development of integrated neuropsychotherapeutic approaches to the treatment of
psychiatric disorders.
2. The development of more valid disease models for research into psychiatric disorders.
3. An improved understanding of the relationship between biology and environment,
particularly in relation to developmental plasticity and emerging pathology.
4. More comparative studies to explore how scientific concepts relating to the human
brain are received and understood in different sociocultural contexts.
5. Research into the legal and ethical implications of recent developments in the
brain sciences, including behavioral screening and manipulation, and emerging
neurotechnologies.
The broad geographical spread of the consulted experts across the whole of Europe,
along with the wide range of disciplines they represent, gives these conclusions a strong
scientific and pan-European endorsement. The next step will be to look closely into these
five selected topics, in terms of research strategy, science policy, societal implications,
and legal and ethical frameworks.
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INTRODUCTION
According to recent estimates, ∼165 million European citizens
will suffer from mental illness in a given year (Wittchen et al.,
2011). This equates to around 38% of the European population
affected by mental illness alone. Unlike diseases such as cancer
or heart disease, the primary burden of brain disorders is linked
to disability. Thus, the combination of mental illness and neu-
rological disorders is responsible for around 1 in 3 years of life
lost to disability or premature mortality in women and 1 in 4
years in men (Wittchen et al., 2011). Yet despite this enormous
societal burden, research investment aimed at the prevention and
treatment of brain disorders is much lower than that provided
for cancer or other areas of research such as information technol-
ogy and agriculture (Nature Editorial, 2011; Insel and Sahakian,
2012).
Irrespective of the level of research investment directed toward
brain disorders, it has become apparent that, after the first
boom of pharmacological treatment possibilities for brain disor-
ders, pharmacological solutions are appearing at a much slower
rate than anticipated. The number of new drugs entering the
pipeline for the treatment of brain disorders, in particular men-
tal illness, has declined dramatically (Miller, 2010). As a result,
there is now a dramatic discrepancy between what is needed
and what is being done to meet that need. Yet hope is to
be found in fields such as psychotherapy. Psychotherapy has
made tangible advances over the last 10–15 years, and in many
cases such treatment is at least as effective as drug therapy,
while in some disorders the combination of pharmacological
treatment and psychotherapy has demonstrated the best results
(Cuijpers et al., 2011).
Understanding brain function is not only of use to medicine—
it is important for all aspects of individual health and wellbeing.
Many psychiatric disorders are known to begin during childhood
and adolescence, at a time when brain plasticity is also critically
important to learning and socialization, for instance. Insights
into both healthy development and pathology could therefore
have implications that extend well beyond the treatment and
prevention of disease. In fact, insights into brain function are
now beginning to raise important questions about how we deter-
mine legal responsibility or how we understand the processes
underlying economic decision-making.
Despite the wide-ranging importance of the brain sciences,
there is a widespread lack of awareness of the issues at stake.
Societal understanding of neuroscience research is both limited
and plagued by misconceptions (Racine et al., 2005). But public
understanding is not the only problem area. Institutions from
schools to courts are increasingly in need of reliable informa-
tion on brain function and its implications in their specific areas
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of interest. Likewise, researchers in the various different fields
that make up the brain sciences would all benefit from a greater
awareness of their respective contributions and viewpoints.
This perspective is based on discussions held during a 1-day
workshop in Berlin in December 2011 as part of the European
Science Foundation (ESF) strategic initiative The Human Brain:
From Cells to Society. The meeting brought together experts in
fields ranging from philosophy and anthropology through clinical
neuroscience to cellular and molecular neurobiology. The docu-
ment is intended to provide a first step in a long-term discussion
of future research and practice in light of the changes occurring
in our understanding of the human brain. It should be empha-
sized that it has not been the intention of the current paper to
provide specific recommendations for action. Rather, it is a first
step designed to narrow the overarching field of “The Human
Brain—fromCells to Society” to a limited number of specific top-
ics that are of current relevance due to their societal implications
or because they hold particular promise for important scientific
breakthroughs. The list of recommended topics that you will find
at the end of the report is a reflection of the agreement reached by
the participants. The broad geographical spread of the consulted
experts across the whole of Europe, along with the wide range of
disciplines they represent, gives these conclusions a strong scien-
tific and pan-European endorsement. The next step will be to look
closely into these five selected topics, in terms of research strategy,
science policy, societal implications, and legal and ethical frame-
works. Only after these carefully managed further steps, will we
be able to expect thorough recommendations. The ESF initiative
“The Human Brain—from Cells to Society” intends to facilitate
this process and, where possible, to support scientists and mem-
ber organizations in that endeavor. We encourage all stakeholders
concerned to join us and to take up this challenge.
LEVELS OF ORGANIZATION—LEVELS OF UNDERSTANDING
The human brain can be understood on a number of levels, from
the genes that control its development and physiology through
to the behavior it generates and even beyond to social and cul-
tural phenomena. These different levels are often understood in
terms of a functional hierarchy. Thus, gene expression deter-
mines the molecular composition of the brain, which in turn
defines the basic building blocks for the cells that will regulate
its physiology. At the next level, neuronal connectivity, defined
by synaptic interactions, underlies the establishment of micro-
circuits and, ultimately, the gross connectivity of brain regions.
How these levels of organization translate into complex behav-
ior is only just beginning to be understood, yet it seems clear
that this brain organization at least provides the foundations for
behavioral expression.
Such a hierarchy is also reflective of the approaches used
to investigate the brain. The genetic research community, for
instance, has focused on identifying genes that control the differ-
entiation and connectivity of neurons in the developing brain, as
well as those gene variants that are associated with specific behav-
iors or neuropsychiatric disorders. Similarly, neuroanatomists
and physiologists have explored the role of different brain areas
in controlling specific functions and psychologists have sought
insight into the behavioral interactions between individuals
within a social or cultural context. Focusing research on one level,
however, can restrict our capacity to achieve a truly mechanistic
understanding of the brain.
Many of the basic building blocks of the brain, in terms
of genetic and molecular components, are now understood.
The human genome is sequenced and many of the products of
gene expression are characterized. Yet the way in which these
components influence the behavioral output of the human brain
are largely limited to associations between gene variants or
neurochemical profiles (e.g., levels of monoamine neurotrans-
mitters) and behavioral disorders (Burmeister et al., 2008; Shyn
and Hamilton, 2010). The challenge for the future will be to
gain insight into how those genes affect the cellular composition
and synaptic organization of the brain, and how this determines
the organization of microcircuits and higher-level regional
organization and connectivity. The same principles apply to
research focused on other levels such as synaptic physiology or
microcircuits.
We must be wary of taking a unidirectional, biological reduc-
tionist view in our attempts to understand brain function, how-
ever. In some areas of the brain sciences, the principle that biology
influences behavior is well accepted without a similar recognition
of the effects of psychosocial interactions on biology. Yet psy-
chosocial interactions such as maternal support in childhood are
already known to influence brain structure (Luby et al., 2012).
Just as each step must be understood from genes and molecules
to behavior and social interaction, therefore, so must the effects
of psychosocial interactions be traced back (Hein et al., 2010).
EXPANDING VIEWS OF DEVELOPMENT AND PLASTICITY
Since antiquity, philosophers and scientists have debated the role
of nature and nurture in the development of human behavioral
and cognitive features. The challenge for the brain sciences is
therefore now to embrace an expanded view of development
and plasticity that focuses on gene–environment interactions
(Bendesky and Bargmann, 2011). Examples of the shifting view
of acquired and innate characteristics in the developing human
brain can be found in research into language development in
human infants. Comparison of cry patterns in new-born infants
exposed to German or French in the womb, for instance, indicates
that the prosodic features of the language are present in infant
cries (Mampe et al., 2009). Thus, an acquired feature of language
is already apparent at birth. Such features, however, are thought
to be dependent upon a biological predisposition for melody per-
ception and production (Mampe et al., 2009). Thus, even before
birth, a clear distinction between nature and nurture is difficult
to draw.
Whether a characteristic is acquired prenatally or postnatally,
it is clear that certain features of language and cognition usually
develop at a certain stage. This has led to the view that there are
windows of opportunity during which a characteristic becomes
fixed (Kuhl, 2010). This view is influenced by the observation of
critical periods during which features such as visual perception
become established (Wiesel and Hubel, 1963). But research has
now begun to question this linear view. In language development,
for instance, Japanese adults who have had limited exposure to
English are generally understood to have lost the capacity to
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contrast between /r/ and /l/ phonemes. Thus, once a critical
period or window of opportunity has passed, those individuals
will no longer be able to learn and reproduce this distinction.
Recent studies have shown, however, that the distinction can still
be learnt under the right conditions (Zhang et al., 2009). Thus,
previous assumptions about the limits of developmental plasticity
may not always hold.
The realization that critical periods for the development and
acquisition of neural functions may not be as fixed as once
thought suggests that it is now time to take a wider view of devel-
opment and plasticity. It is time for research to move beyond
looking at infants alone and seek to understandmore clearly what
happens between infancy and adulthood. This is of relevance not
only to cognition and language but also to emotional and psy-
chosocial development. Many psychiatric disorders, for instance,
are understood to have their origins in puberty, yet very little is
understood about what actually happens to the brain during this
period (Paus et al., 2008). If we can improve our understand-
ing of developmental processes and potential pathology across
a much wider age range, we will increase the opportunity for
early intervention and preventive strategies. Ultimately, this will
require long-term longitudinal studies (Schumann et al., 2010).
Importantly, if we are to begin to understand the relationship
between the environment and biological processes, such studies
will need to encompass all levels of understanding, from genes to
social interaction.
TRANSLATING KNOWLEDGE INTO PRACTICE—TREATMENT
AND PREVENTION OF BRAIN DISORDERS
The treatment of mental illness has for decades been highly
polarized. These two sides could be described as “bottom-up”
and “top-down” but we prefer the more classical terminology
of “biological” and “psychological.” Even though this terminol-
ogy may be considered slightly naive, it emphasizes that these
different approaches stem from different disciplines and have
a whole different academic tradition behind them. This disci-
plinary issue is key to the current paper. One side in the debate,
which we will refer to as “biological psychiatry,” has champi-
oned the view that mental illness has an organic basis and that
treatment must therefore be focused on physical (generally phar-
macological) correction of a biological defect. The other side,
primarily psychosocial psychiatry and psychology, has focused on
the psychological causes of disturbance and sought psychological
solutions to correct it. The forceful opinions expressed by both
sides reflect a strong ideological division that largely continues
the mind–body dichotomy that has fueled philosophical debate
for centuries.
The separation of biology and psychology in our understand-
ing of the causes and treatment of mental illness also highlights
major gaps in our understanding of brain function. As we move
away from a biological reductionist view of the human brain, we
can begin to explore how psychosocial interactions influence the
structure and function of the brain in the same way as its genetic,
molecular, and cellular organization can regulate cognition and
psychology. As a result, we can begin to understand psychosocial
interventions not only in terms of their psychological effects but
also their influence on the organic structure and physiology of
the brain. This could prove to be a particularly fruitful avenue of
exploration.
Following the major advances that were made in the psy-
chopharmacological treatment of mental illness, psychother-
apeutic approaches—by which we understand a wide range
of therapeutic interactions or treatments, including psychiatry,
clinical psychology, counseling psychology, occupational ther-
apy and psychoanalysis—have now begun to show effect sizes
that are equal or superior to pharmacotherapy in many disor-
ders (Cuijpers et al., 2011). Moreover the combination of the
two approaches has proven to be the most effective in major
chronic psychiatric disorders such as bipolar affective disorder
or schizophrenia. Randomized controlled trials in bipolar dis-
order have shown that maintenance pharmacological treatment
and psychotherapeutic interventions in combination had the best
effect on long-term outcomes, such as relapse or rehospitalization
(Vieta et al., 2009). Another example is in the treatment of bor-
derline personality disorder. Reviews of current evidence suggest
that pharmacotherapy may be useful for the treatment of indi-
vidual symptoms, but it is not an effective approach to reducing
the overall severity of borderline personality disorder (Lieb et al.,
2010). In contrast, preliminary findings in small studies have
supported the potential efficacy of psychotherapeutic approaches
(Binks et al., 2006). More recent trials have continued to show
evidence supporting the efficacy of psychotherapeutic interven-
tions (Bateman and Fonagy, 2008, 2009; Farrell et al., 2009; Paris,
2009). It remains an open question, however, exactly what effect
these approaches have on the brain. Interestingly, the specificity
of a therapeutic intervention can be considered an open question
for both psychotherapy and pharmacotherapy. Any effect on one
part of the brain can be assumed to affect the brain as a whole.
Greater insight is therefore required into both the specific and
wider consequences of any therapeutic intervention.
As we develop insights into the effects of psychotherapy and
psychosocial interventions on the brain, it should be possible to
tailor the treatment to individual needs and develop a truly neu-
ropsychotherapeutic approach. In the short term, however, there
are already steps that can be taken toward an integration of biol-
ogy and psychology. For instance, pharmacological interventions
are now becoming available that could be used to facilitate the
use of psychotherapy in a variety of psychiatric disorders. It has
been suggested that the use of certain neuropeptide drugs, such as
oxytocin and vasopressin, could facilitate interaction-based psy-
chotherapy for disorders involving early attachment disruption
or abnormal social interaction such as social anxiety disorder and
borderline personality disorder (Meyer-Lindenberg et al., 2011).
Such approaches are particularly exciting given the enormous dif-
ficulty associated with the treatment of social disorders. They
also highlight an overall principle of combining biological and
psychological interventions to enhance the potential efficacy of
treatment. In the next 10 years, it can reasonably be expected that
substantial advances will be achieved in this way.
The longer-term goal of research into the treatment of brain
disorders is of course to move away from symptomatic treatments
and toward therapies that target the underlying etiology. The
hurdles that must be overcome to move beyond symptomatic
treatment in psychiatric disorders are particularly challenging,
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however, since we must first develop amuchmore detailed under-
standing of the etiology of the disorders. In conditions such as
schizophrenia, for instance, only very fragmented information
is available on the underlying pathology and even less on the
mechanisms leading to the development of symptoms (Stöber
et al., 2009). Recently, findings from various fields have begun to
be synthesized to show that dysfunction of inhibitory interneu-
rons might be a final common pathway that leads to divergent
symptoms in schizophrenia and other disorders (Marin, 2012).
Continuing such research efforts aimed at understanding the
underlying pathophysiology of brain disorders will be of far more
than merely academic interest—it is absolutely crucial to their
future treatment and prevention.
Experimental testing of therapeutic interventions is heavily
dependent upon the use of animal models under clearly defined
conditions. Most psychiatric disorders are diagnosed based on
a constellation of symptoms (American Psychiatric Association,
2000), and this presents major problems for the establishment
of reliable animal models. It is unlikely, for instance, that a
single animal model will unite all of the symptoms required
for the diagnosis of complex psychiatric disorders such as
schizophrenia, depression, or personality disorder. The focus
must therefore be on developing models that reflect the patho-
physiology of brain diseases. One important step toward this
goal will be the identification of definitive biomarkers for psy-
chiatric disorders, and this will also offer clear clinical benefits
for improved diagnosis. Another avenue of interest for psychi-
atric research is the development of in vitro disease models based
on induced pluripotent stem cells, which will also serve to iden-
tify biomarkers and molecular disease pathways (Brennand et al.,
2012).
TOWARD A BRAIN-AWARE SOCIETY—DEALING WITH THE
IMPLICATIONS OF ADVANCES IN THE BRAIN SCIENCES
Many advances in biomedical research have had social and soci-
etal implications. Perhaps the best example is that of genetics,
where much debate has arisen around privacy and (mis)use of
personal information (Clayton, 2003). The various disciplines
that together form the brain sciences, however, merit specific con-
sideration. Since research in this area touches on areas such as
identity, free will, and responsibility, it has the potential to influ-
ence the very way in which we see ourselves as human beings.
As a result, the impact of the brain sciences extends far beyond
health and education and includes areas such as legal responsi-
bility, treatment vs. enhancement, military applications, and the
ethical limits of behavioral assessment.
The identification of biomarkers to facilitate the diagnosis
of psychiatric disorders has important implications (Singh and
Rose, 2009). Biomarkers are not only indicators of pathology;
they also have the potential to predict susceptibility to illness.
Thus, if we were able to recognize early pathophysiological signs
of a disease such as schizophrenia in children, wemight ultimately
be able to avert its course. But there are also significant dangers of
the indiscriminate or ill-informed use of biomarkers for behav-
ioral traits. The same biomarkers that are used for diagnosis or
risk stratification of psychiatric disorders could in principle be
used to identify individuals who are likely to display the behaviors
or personality traits that define them.
Screening for individual biomarkers of behavioral traits could
focus attention on the individual and away from social and
environmental factors (Singh and Rose, 2009). Many childhood
behavioral problems, whether or not classified as specific disor-
ders, are thought to have links with youth and adult criminality
or antisocial behavior, for instance. This is the case for psychiatric
diagnoses such as attention deficit hyperactivity disorder, where
concerns have already been raised about the risk-benefit ratio of
the use of medication and the process of medicalization in very
young children (Singh and Rose, 2009). Categorization of chil-
dren as potential future delinquents carries with it the potential
to alter their perception of themselves and the way that they are
treated by others at a very early stage in their life trajectories. We
must therefore ask ourselves whether we have sufficient insight
into the potential neuropsychological effects of this sort of early
risk prediction. For instance, how will a child who is identified
as at increased risk of future antisocial behavior or criminality
be treated by those responsible for his or her welfare? Likewise,
how will a child’s self-image be affected by this knowledge and by
the resulting changes in behavior that might occur in caregivers
and other significant adults? These and other related issues must
be considered carefully to avoid potentially helpful information
having unexpected or even obviously damaging consequences.
Furthermore, similar questions apply to screening for learning
deficits and early cognitive traits applicable to child education and
social development.
Concerns about discrimination and stigmatization of individ-
uals identified as being at risk for future psychiatric illness or
as already having neuropsychological abnormalities highlights a
current concern over the potential misuse of the brain sciences.
On the one hand, evidence suggests that there is a great deal
of plasticity in brain function and that even apparently “fixed”
traits can be changeable under the right conditions. Yet on the
other hand, public perception and even views held among pro-
fessionals can reflect a powerfully deterministic view of behavior.
According to such a deterministic view, someone who carries
biomarkers for future behavioral traits or mental illness is at risk
of discrimination rather than being provided with an opportu-
nity for support and intervention that allows positive change. Of
course, intervention itself can be either supportive or coercive.
The potential for social control based on behavioral norms, even
when a non-deterministic view of behavior is adopted, is clearly
quite substantial. As has been argued elsewhere, the only way in
which to understand the social implications of a biomarker is to
undertake detailed qualitative research in a wide section of the
population (Singh and Rose, 2009). The findings of such research
will allow policies to be established that maximize the benefit and
minimize the potential harm associated with the introduction of
biomarkers for psychiatric disorders.
Questions of determinism and plasticity also influence our
view of legal and social responsibility (Freeman, 2011; Buchen,
2012). According to a deterministic view of behavior, individuals
could be deemed as not responsible for their actions if it is shown
that their brain structure or physiology, for example, is associated
with a particular criminal behavior. Equally, those who carry
biomarkers of behavioral traits such as propensity to violence
could be at risk of being detained or controlled pre-emptively in
a society that is increasingly unwilling to accept perceived risk
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(Eastman and Campbell, 2006; Buchen, 2012). If probabilistic
indicators of predisposition are mistakenly interpreted as bio-
logical determinants, we risk seeing them as functioning entirely
in the absence of other environmental and psychological factors.
Under such conditions, the risk of neuroscience being used as a
tool to support oppressive social policies is very real.
Given such risks, can we reasonably expect juries and the legal
profession to be sufficiently versed in neuroscience, or indeed sci-
ence in general, to understand the nature and reliability of the evi-
dence presented to them? Scientific evidence is usually employed
in law to determine whether an individual did or did not com-
mit a crime. In the case of behavioral neuroscience, however, the
purpose of the evidence is to decide whether the defendant had
wrongful intent (Eastman and Campbell, 2006). Under these con-
ditions, neuroscientists should perhaps be evenmore wary of how
their expert status could be misused or exploited. If inappropriate
responsibility is given to neuroscientists as arbiters of individual
intent, there is a risk of returning to a situation somewhat akin to
opinions on the goodness of someone’s élan vital. The scientific
community therefore has a responsibility to ensure public under-
standing of the potential roles and limitations of neuroscience
research in legal and social contexts.
If we are to make practical use of scientific concepts, we must
understand the sociocultural context in which they are received
and understood. On one level, the influence of neuroscience
will be culturally dependent, as has been observed in relation to
other areas of biomedical science such as immunology (Martin,
1994). The concept of cultural dependence, however, can also
apply to knowledge communities. How, for instance, do core con-
cepts differ between neurobiology and psychology, or between
social psychology and anthropology? Ultimately, the importance
of understanding the human brain requires that disciplinary com-
munities be brought together to reach a common goal. Yet this
requires the different groups to be able to communicate effec-
tively with each other. There is currently very little information
available on how key concepts such as empathy are understood in
different knowledge communities (e.g., brain imaging and social
psychology). Indeed, anecdotal evidence suggests that some fields
are hostile toward the approaches and thinking of others. The
effectiveness of future research will therefore be dependent on
identifying ways to ensure that interdisciplinary efforts lead to
cross-fertilization rather than cross-sterilization.
Any proposed brain-aware society must reflect the different
ways in which we understand ourselves as human beings. This
can be described in positivist, interpretational, and phenomeno-
logical terms. Positivist descriptions focus on the underlying
cause of a psychological phenomenon, interpretational descrip-
tions on our beliefs about the cause of the phenomenon, and
phenomenological descriptions on our reasons for those beliefs.
Neuroscience, however, currently focuses almost exclusively upon
positivist descriptions. For instance, by attempting to describe
human behavior in terms of underlying biological or neurochem-
ical changes, it seeks to provide an underlying physical cause for
psychological phenomena. If society as a whole is to embrace
neuroscience and become more brain aware in its approaches to
education, the legal system, and social responsibility, discussion
must also leave room for interpretational and phenomenological
understanding.
Finally, a brain-aware society must also be equipped to deal
appropriately with developing technologies. The widespread use
of techniques such as functional magnetic resonance imaging and
positron emission tomography has yielded important insights
into brain function. Likewise, technologies such as cochlear
implants have been of enormous benefit to large numbers of
people. More recently, opportunities have developed for neuro-
robotics and brain stimulation to play important roles in medical
or other applications. However, with these developments, we
must now begin to address the social implications of tools that
could allow information not only to be read from the brain but
also perhaps written back into it (Wolpe et al., 2010; Heinrichs,
2012). The potential for such technologies to invade the integrity
and freedom of the individual is quite real. Society may need to
determine, for instance, what belongs to the individual and what
can be decoded in the public interest. Likewise, the potential use
of brain stimulation to introduce information into the human
brain or enhance its function will require careful ethical moni-
toring. These and other questions, such as military applications
of neurotechnologies (Brain Waves Module, 2012), are in need of
urgent debate at all levels of an emerging brain-aware society.
CONCLUSIONS AND FUTURE DIRECTIONS
In summary, discussions among participants highlighted five key
opportunities for important advances to be made in our under-
standing of the human brain, from cells to society (see text
box). The first opportunity expresses the overarching biomedi-
cal goal for which the two subsequent opportunities are required.
Opportunities 4 and 5 fall under another banner addressing very
different but equally important and far-reaching issues related to
societal challenges and impact. Each of these five areas is expected
to capitalize on existing research strengths in Europe while also
embracing the broad relevance of the brain sciences to society.
This should be taken as the first step in a long-term process.
The next step will be to look closely into the five selected topics,
in terms of research strategy, science policy, societal implications,
and legal and ethical frameworks. This should lead to specific rec-
ommendations that allow for an effective implementation. The
ESF initiative “The Human Brain—from Cells to Society” was
established to facilitate this process and, where possible, to sup-
port scientists and member organizations in that endeavor. We
encourage all stakeholders concerned to join us and to take up
this challenge.
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OPPORTUNITIES TO ADVANCE OUR UNDERSTANDING OF
THE HUMAN BRAIN—FROM CELLS TO SOCIETY
1. The development of integrated neuropsychotherapeutic
approaches is likely to yield significant benefits in the
treatment of psychiatric disorders. Such approaches will
be based on improvements in our understanding of the
interplay between neurobiological and psychological factors.
As experience is gained in working at the interface between
biology and psychology, similar principles can be applied in
other areas, such as brain-aware education.
2. Research into psychiatric disorders would be facilitated by
the development of more valid disease models. Greater
understanding of the pathophysiology of these diseases will
be required in order to overcome the limitations of focusing
on behavior alone. Such efforts will be facilitated by the
identification of reliable biomarkers, which themselves will
offer clinical benefits by facilitating precise diagnosis.
3. A major opportunity for future developments in the brain
sciences is to improve our understanding of the relationship
between biology and environment, particularly in relation to
developmental plasticity and emerging pathology. A particu-
lar area in which significant progress can be achieved is an
improved understanding of factors determining healthy and
pathological brain development in children and adolescents.
4. A truly integrated understanding of the human brain requires
extensive cross-disciplinary understanding. Similarly, a truly
brain-aware society requires a wider trans-disciplinary knowl-
edge transfer in order to facilitate public understanding. More
comparative studies are therefore needed to explore how
scientific concepts are received and understood in different
sociocultural contexts.
5. Many questions remain to be answered regarding the legal
and ethical implications of recent developments in the brain
sciences. Particularly pressing issues to address are the
effects on our understanding of legal responsibility and the
uses of behavioral screening and manipulation. As a matter
of urgency, preparations must also be made for society to
deal with the implications of emerging neurotechnologies.
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